Why Younger Women Are Getting Breast Cancer at Record Rates (And How to Reduce Your Risk)

14 Oct 2026 · 65 min
1:05:09

In this episode of The Dr. Hyman Show, Dr. Mark Hyman interviews Dr. Thaïs Aliabadi, a gynecologist and women’s‑health advocate, about the alarming rise of breast cancer in younger women and why outcomes are worsening. They begin by highlighting systemic access problems—half of U.S. counties lack an OB‑GYN—and the frequent dismissal of women’s symptoms in clinical settings. Dr. Aliabadi explains how dense breast tissue makes standard 2‑D mammograms miss 15‑25 % of cancers and urges women to request 3‑D mammography, supplemental breast ultrasound, and, for high‑risk patients, annual breast MRI. The conversation moves to personalized risk assessment using the Tyrer‑Cuzick calculator, which incorporates age, breast density, family history, hormonal factors, and atypical biopsies. They discuss genetic testing (BRCA, PALB2, CHEK2, ATM, etc.) and polygenic risk scores that capture hundreds of small‑effect variants, noting that most breast‑cancer patients lack a single high‑penetrance mutation. Dr. Aliabadi shares her own story of a 37 % lifetime risk revealed by the calculator, leading to a double mastectomy after a missed diagnosis. The hosts then explore metabolic and inflammatory drivers—obesity, insulin resistance, chronic stress, poor sleep, alcohol, and environmental xenoestrogens—as well as the role of the gut microbiome (estrobolome) in estrogen metabolism. They introduce a comprehensive functional‑medicine lab panel (A1c, lipid particles, ApoB, hs‑CRP, homocysteine, vitamin D, B12, iron, hormone panels) and emphasize that many clinicians overlook these tests. The discussion expands to PMOS (formerly PCOS), describing it as a metabolic‑endocrine disorder linked to insulin resistance, hyperandrogenism, inflammation, and increased cancer risk. Hormone replacement therapy (HRT) is debated: while HRT alleviates perimenopausal symptoms and protects bone and cognition, it must be individualized based on a woman’s calculated breast‑cancer risk, genetic profile, and whether she is on risk‑reduction agents such as tamoxifen. Throughout, Dr. Aliabadi stresses patient empowerment—knowing one’s lifetime risk, demanding appropriate imaging, and advocating against dismissal. The episode also contains several sponsor reads for health‑related products and services.

Chapters

More from AI

0:29
youtube.com

Why You Can't Quit Sugar (it's not your fault)

1d ago
0:35
youtube.com

Why you need a 10-day Detox to Heal Chronic Illness

3d ago
36:21
youtube.com

If I Could Only Do ONE Thing to Treat Chronic Disease, This Would Be It

4d ago
8:27
youtube.com

Urolithin A Repairs Your Mitochondria (And 60% of People Can't Make It)

1w ago
1:19:43
youtube.com

This Is Why 99% of Skin Conditions Don't Heal — And What Dermatologists Won't Tell You

1w ago
24:57
youtube.com

What I Actually Do When I Feel a Cold Coming On (It's Not Vitamin C)

1w ago
1:27:17
youtube.com

Calories Are Down. Exercise Is Up. So Why Is Obesity Exploding?

2w ago
12:22
youtube.com

5 Things You Think Are Extending Your Life (That Are Actually Doing Nothing)

2w ago
1:07:56
youtube.com

The Real Reason You Can't Stop Eating (It's Not Willpower)

3w ago
26:25
youtube.com

A Doctor's Honest Guide to The Grocery Store (What's Worth Worrying About)

3w ago
1:14
youtube.com

Why you need to start strength training today #strengthtraining #healthyaging #fitness

4w ago
See all content